Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 2
1966 3
1968 2
1969 2
1970 3
1971 4
1974 3
1975 4
1976 5
1977 2
1978 1
1979 4
1980 4
1981 4
1982 5
1983 3
1984 8
1985 4
1986 4
1987 6
1988 6
1989 12
1990 11
1991 10
1992 14
1993 6
1994 9
1995 14
1996 23
1997 13
1998 29
1999 24
2000 18
2001 16
2002 12
2003 17
2004 18
2005 12
2006 15
2007 9
2008 18
2009 10
2010 13
2011 5
2012 8
2013 6
2014 13
2015 12
2016 3
2017 4
2018 11
2019 8
2020 7
2021 10
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

489 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. Among authors: yanagawa h. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Clinical Trial.
Insertional gene fusion technology.
Doi N, Yanagawa H. Doi N, et al. Among authors: yanagawa h. FEBS Lett. 1999 Aug 20;457(1):1-4. doi: 10.1016/s0014-5793(99)00991-6. FEBS Lett. 1999. PMID: 10486551 Free article. Review.
A digest from evidence-based clinical practice guideline for IgA nephropathy 2020.
Suzuki H, Kikuchi M, Koike K, Komatsu H, Matsuzaki K, Takahashi K, Ichikawa D, Okabe M, Obata Y, Katafuchi R, Kihara M, Kohatsu K, Sasaki T, Shimizu A, Nakanishi K, Fukuda A, Miyazaki Y, Muto M, Yanagawa H, Suzuki Y, Fujimoto S, Furuichi K, Okada H, Narita I; Committee of Clinical Practical Guideline for IgA Nephropathy 2020. Suzuki H, et al. Among authors: yanagawa h. Clin Exp Nephrol. 2021 Dec;25(12):1269-1276. doi: 10.1007/s10157-021-02095-8. Epub 2021 Sep 26. Clin Exp Nephrol. 2021. PMID: 34564790 No abstract available.
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
Moldoveanu Z, Suzuki H, Reily C, Satake K, Novak L, Xu N, Huang ZQ, Knoppova B, Khan A, Hall S, Yanagawa H, Brown R, Winstead CJ, O'Quinn DB, Weinmann A, Gharavi AG, Kiryluk K, Julian BA, Weaver CT, Suzuki Y, Novak J. Moldoveanu Z, et al. Among authors: yanagawa h. J Autoimmun. 2021 Mar;118:102593. doi: 10.1016/j.jaut.2021.102593. Epub 2021 Jan 25. J Autoimmun. 2021. PMID: 33508637 Free PMC article.
Research Ethics Consultation in Nursing Studies.
Kane C, Sakaguchi S, Chuma M, Yagi K, Takechi K, Aoe Y, Takagai T, Yanagawa H. Kane C, et al. Among authors: yanagawa h. J Empir Res Hum Res Ethics. 2022 Feb-Apr;17(1-2):63-69. doi: 10.1177/15562646211036577. Epub 2021 Aug 10. J Empir Res Hum Res Ethics. 2022. PMID: 34374568
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study.
Hamano H, Mitsuhashi C, Suzuki Y, Zamami Y, Tsujinaka K, Okada N, Niimura T, Hayama T, Imai T, Ishida S, Sakamoto K, Goda M, Takechi K, Yagi K, Chuma M, Horinouchi Y, Shinomiya K, Ikeda Y, Kirino Y, Nakamura T, Yanagawa H, Hamada Y, Ishizawa K. Hamano H, et al. Among authors: yanagawa h. Biol Pharm Bull. 2021;44(4):478-484. doi: 10.1248/bpb.b20-00609. Biol Pharm Bull. 2021. PMID: 33790099 Free article.
489 results